Lundeen, Mark http://orcid.org/0000-0002-9396-2836
Hurd, Jason L. http://orcid.org/0000-0002-1621-5693
Hayes, Matthew http://orcid.org/0000-0003-4833-9508
Hayes, Meredith http://orcid.org/0000-0001-9152-0914
Facile, Tiffany R. http://orcid.org/0000-0002-2801-7985
Furia, John P. http://orcid.org/0000-0001-9551-4503
Maffulli, Nicola http://orcid.org/0000-0002-5327-3702
Alt, Christopher http://orcid.org/0000-0003-1487-4502
Alt, Eckhard U. http://orcid.org/0000-0002-6687-139X
Schmitz, Christoph http://orcid.org/0000-0002-4065-1241
Pearce, David A. http://orcid.org/0000-0002-0707-063X
Article History
Received: 18 May 2023
Accepted: 3 November 2023
First Online: 7 November 2023
Competing interests
: C.A. is Director of Medical and Scientific Affairs of InGeneron, Inc. (Houston, TX, USA). E.U.A. is Executive Chair of InGeneron. C.S. is Advisory Medical Director of InGeneron. However, InGeneron had no role in study design, data collection and analysis, interpretation of the data, and no role in the decision to publish and write this manuscript. No other potential conflicts of interest relevant to this article were reported.